{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:16:05Z","timestamp":1675988165099},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00347-012-2698-5","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T19:39:25Z","timestamp":1353613165000},"page":"1129-1143","source":"Crossref","is-referenced-by-count":7,"title":["Morbus Beh\u00e7et \u2013 ophthalmologische und allgemeine Aspekte Teil\u00a0I"],"prefix":"10.1007","volume":"109","author":[{"given":"U.","family":"Pleyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hazirolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Winterhalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"St\u00fcbiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"2698_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","volume":"54","author":"Verity","year":"1999","unstructured":"Verity DH, Marr JE, Ohno S et al (1999a) Behcet\u2019s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens 54:213\u2013220","journal-title":"Tissue Antigens"},{"key":"2698_CR2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","volume":"4","author":"Altenburg","year":"2006","unstructured":"Altenburg A, Papoutsis N, Orawa H et al (2006) Epidemiology and clinical manifestations of Adamantiades-Beh\u00e7et disease in Germany \u2013 current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49\u201364","journal-title":"J Dtsch Dermatol Ges"},{"key":"2698_CR3","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/kel329","volume":"45","author":"Direskeneli","year":"2006","unstructured":"Direskeneli H (2006) Autoimmunity vs autoinflammation in Behcet\u2019s disease: Do we oversimplify a complex disorder? Rheumatology 45:1461\u20131465","journal-title":"Rheumatology"},{"key":"2698_CR4","first-page":"81","volume":"44","author":"Zouboulis","year":"1993","unstructured":"Zouboulis CC, Buttner P, Djawari D et al (1993) The HLA pattern in Adamantiades-Behcet\u2019s disease in Germany. Association of occurrence, clinical symptoms and follow-up in 39 patients. Hautarzt 44:81\u201385","journal-title":"Hautarzt"},{"key":"2698_CR5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","volume":"111","author":"Yoshida","year":"2004","unstructured":"Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Beh\u00e7et\u2019s disease in the 1980\u00a0s and 1990\u00a0s. Ophthalmology 111:810\u2013815","journal-title":"Ophthalmology"},{"key":"2698_CR6","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1002\/art.24149","volume":"58","author":"Mahr","year":"2008","unstructured":"Mahr A, Belarbi L, Wechsler B et al (2008) Population-based prevalence study of Beh\u00e7et\u2019s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum 58:3951\u20133959","journal-title":"Arthritis Rheum"},{"key":"2698_CR7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1034\/j.1399-0039.1999.540307.x","volume":"54","author":"Verity","year":"1999","unstructured":"Verity DH, Wallace GR, Vaughan RW et al (1999b) HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behcet\u2019s disease. Tissue Antigens 54:264\u2013272","journal-title":"Tissue Antigens"},{"key":"2698_CR8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/0002-9343(87)90896-5","volume":"83","author":"Chajek-Shaul","year":"1987","unstructured":"Chajek-Shaul T, Pisanty S, Knobler H et al (1987) HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Beh\u00e7et\u2019s syndrome. Am J Med 83:666\u2013672","journal-title":"Am J Med"},{"key":"2698_CR9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.624","volume":"42","author":"Mizuki","year":"2010","unstructured":"Mizuki N, Meguro A, Ota M et al (2010) Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Beh\u00e7et\u2019s disease susceptibility loci. Nat Genet 42:703\u2013706","journal-title":"Nat Genet"},{"key":"2698_CR10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2011.05.029","volume":"128","author":"Geri","year":"2011","unstructured":"Geri G, Terrier B, Rosenzwajg M et al (2011) Critical role of IL-21 in modulating TH17 and regulatory T cells in Beh\u00e7et disease. J Allergy Clin Immunol 128:655\u2013664","journal-title":"J Allergy Clin Immunol"},{"key":"2698_CR11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/rheumatology\/keh236","volume":"43","author":"Mumcu","year":"2004","unstructured":"Mumcu G, Ergun T, Inanc N et al (2004) Oral health is impaired in Beh\u00e7et\u2019s disease and is associated with disease severity. Rheumatology 43:1028\u20131033","journal-title":"Rheumatology"},{"key":"2698_CR12","doi-asserted-by":"crossref","first-page":"681956","DOI":"10.1155\/2011\/681956","volume":"2011","author":"Kaneko","year":"2011","unstructured":"Kaneko F, Togashi A, Saito S et al (2011) Beh\u00e7et\u2019s disease (Adamantiades-Beh\u00e7et\u2019s disease). Clin Dev Immunol 2011:681956","journal-title":"Clin Dev Immunol"},{"key":"2698_CR13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000077332","volume":"36","author":"Aydin","year":"2004","unstructured":"Aydin E, S\u00f6g\u00fct S, Ozyurt H et al (2004) Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Beh\u00e7et\u2019s disease with and without ocular disease. Ophthalmic Res 36:177\u2013182","journal-title":"Ophthalmic Res"},{"key":"2698_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000313546","volume":"45","author":"Kim","year":"2011","unstructured":"Kim TW, Chung H, Yu HG (2011) Chemokine expression of intraocular lymphocytes in patients with Beh\u00e7et uveitis. Ophthalmic Res 45:5\u201314","journal-title":"Ophthalmic Res"},{"key":"2698_CR15","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/art.1780391216","volume":"39","author":"Calguneri","year":"1996","unstructured":"Calguneri M, Kiraz S, Ertenli I et al (1996) The effect of prophylactic penicillin treatment on the course of arthritis episodes in patients with Behcet\u2019s disease. A randomized clinical trial. Arthritis Rheum 39:2062\u20132065","journal-title":"Arthritis Rheum"},{"key":"2698_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.preteyeres.2007.09.002","volume":"27","author":"Deuter","year":"2008","unstructured":"Deuter CM, K\u00f6tter I, Wallace GR et al (2008) Beh\u00e7et\u2019s disease: ocular effects and treatment. Prog Retin Eye Res 27:111\u2013136","journal-title":"Prog Retin Eye Res"},{"key":"2698_CR17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00347-012-2586-z","volume":"109","author":"Pleyer","year":"2012","unstructured":"Pleyer U, Hazirolan D, St\u00fcbiger N (2012) Comments on the pathogenesis of Beh\u00e7et\u2019s disease: a key to understanding new therapies? Ophthalmologe 109:563\u2013567","journal-title":"Ophthalmologe"},{"key":"2698_CR18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s00296-003-0324-1","volume":"24","author":"\u00d6zturk","year":"2004","unstructured":"\u00d6zturk MA, Ertenli I, Kiraz S et al (2004) Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Beh\u00e7et\u2019s disease. Rheumatol Int 24:98\u2013102","journal-title":"Rheumatol Int"},{"key":"2698_CR19","first-page":"177","volume":"103","author":"Dilsen","year":"1986","unstructured":"Dilsen N, Konice M, Aral O (1986) Our diagnostic criteria of Behcet\u2019s disease\u2014an overview, recent advances in Behcet\u2019s Disease. London Royal Society of Medicine Services. Int Congr Sympos Series 103:177\u2013180","journal-title":"Int Congr Sympos Series"},{"key":"2698_CR20","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000074113","volume":"207","author":"Alpsoy","year":"2003","unstructured":"Alpsoy E, Donmez L, Bacanli A et al (2003) Review of the chronology of clinical manifestations in 60 patients with Beh\u00e7et\u2019s disease. Dermatology 207:354\u2013356","journal-title":"Dermatology"},{"key":"2698_CR21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00347-004-1166-2","volume":"102","author":"Krause","year":"2005","unstructured":"Krause L (2005) Adamantiades-Behcet\u2019s disease. Ophthalmologe 102:329\u2013334","journal-title":"Ophthalmologe"},{"key":"2698_CR22","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00347-012-2601-4","volume":"109","author":"Altenburg","year":"2012","unstructured":"Altenburg A, Mahr A, Maldini C et al (2012) Epidemiology and clinical aspects of Adamantiades-Beh\u00e7et disease in Gemany: current data. Ophthalmologe 109:531\u2013541","journal-title":"Ophthalmologe"},{"key":"2698_CR23","first-page":"278","volume":"19","author":"Masuda","year":"1975","unstructured":"Masuda K (1975) A nation-wide survey of Beh\u00e7et\u2019s disease in Japan. Jpn J Ophthalmol 19:278\u2013285","journal-title":"Jpn J Ophthalmol"},{"key":"2698_CR24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3346\/jkms.2003.18.2.231","volume":"18","author":"Bang","year":"2003","unstructured":"Bang DS, Oh SH, Lee KH et al (2003) Influence of sex on patients with Behcet\u2019s disease in Korea. J Korean Med Sci 18(2):231\u2013235","journal-title":"J Korean Med Sci"},{"key":"2698_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/0-306-48382-3_5","volume":"528","author":"Shahram","year":"2003","unstructured":"Shahram F, Davatchi F, Nadji A et al (2003) Recent epidemiological data on Behcet\u2019s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31\u201336","journal-title":"Adv Exp Med Biol"},{"key":"2698_CR26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R et al (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373\u2013380","journal-title":"Am J Ophthalmol"},{"key":"2698_CR27","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.43.1.70","volume":"43","author":"Davies","year":"1984","unstructured":"Davies PG, Fordham JN, Kirwan JR et al (1984) The pathergy test and Behcet\u2019s syndrome in Britain. Ann Rheum Dis 43(1):70\u201373","journal-title":"Ann Rheum Dis"},{"key":"2698_CR28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3349\/ymj.2007.48.4.573","volume":"48","author":"Alpsoy","year":"2007","unstructured":"Alpsoy E, Zouboulis CC, Ehrlich GE (2007) Mucocutaneous lesions of Beh\u00e7et\u2019s disease. Yonsei Med J 48:573\u2013585","journal-title":"Yonsei Med J"},{"key":"2698_CR29","first-page":"146","volume":"16","author":"Ilknur","year":"2006","unstructured":"Ilknur T, Pabu\u00e7\u00e7uoglu U, Akin C et al (2006) Histopathologic and direct immunofluorescence findings of the papulopustular lesions in Beh\u00e7et\u2019s disease. Eur J Dermatol 16:146\u2013150","journal-title":"Eur J Dermatol"},{"key":"2698_CR30","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10067-011-1694-5","volume":"30","author":"Davatchi","year":"2011","unstructured":"Davatchi F, Chams-Davatchi C, Ghodsi Z et al (2011) Diagnostic value of pathergy test in Behcet\u2019s disease according to the change of incidence over the time. Clin Rheumatol 30:1151\u20131155","journal-title":"Clin Rheumatol"},{"key":"2698_CR31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archneur.1989.00520390031011","volume":"46","author":"Serdaroglu","year":"1989","unstructured":"Serdaroglu P, Yazici H, Ozdemir C et al (1989) Neurologic involvement in Behcet\u2019s syndrome. A prospective study. Arch Neurol 46:265\u2013269","journal-title":"Arch Neurol"},{"key":"2698_CR32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004150170154","volume":"248","author":"Siva","year":"2001","unstructured":"Siva A (2001) Vasculitis of the nervous system. J Neurol 248:451\u2013468","journal-title":"J Neurol"},{"key":"2698_CR33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10620-008-0337-4","volume":"54","author":"Ebert","year":"2009","unstructured":"Ebert EC (2009) Gastrointestinal manifestations of Beh\u00e7et\u2019s disease. Dig Dis Sci 54:201\u2013207","journal-title":"Dig Dis Sci"},{"key":"2698_CR34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"BenEzra","year":"1986","unstructured":"BenEzra D, Cohen E (1986) Treatment and visual prognosis in Beh\u00e7et\u2019s disease. Br J Ophthalmol 70:589\u2013592","journal-title":"Br J Ophthalmol"},{"key":"2698_CR35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09273948.2012.655882","volume":"20","author":"Hazirolan","year":"2012","unstructured":"Hazirolan D, Sungur G, Duman S (2012) Demographic, clinical, and ocular features in patients with late-onset Beh\u00e7et disease. Ocul Immunol Inflamm 20:119\u2013124","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2698-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00347-012-2698-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-012-2698-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:51:50Z","timestamp":1559051510000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00347-012-2698-5"}},"subtitle":["\u00c4tiologie, Pathogenese und Diagnostik"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2698"],"URL":"https:\/\/doi.org\/10.1007\/s00347-012-2698-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"value":"0941-293X","type":"print"},{"value":"1433-0423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}